InvestorsHub Logo
Followers 126
Posts 3170
Boards Moderated 0
Alias Born 08/24/2015

Re: georgebailey post# 577778

Saturday, 03/18/2023 2:07:34 AM

Saturday, March 18, 2023 2:07:34 AM

Post# of 693267
The slide shows DC vaccine plus placebo, plus Poly ICLC, plus Resiquimod (also a Toll-like-receptor agonist like Poly ICLC, just different receptor ligand). The graph shows 50% survival at 100 months (8+ years). Dr. Liau would like to obviously expand these trials using different dosing, etc. and go on to a registration trial with NWBO for approvals
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News